Background/Objectives: Juvenile myelomonocytic leukemia (JMML) is a rare and very aggressive pediatric myelodysplastic/myeloproliferative neoplasm with molecular heterogeneity and constitutive activation of the RAS signaling pathway. The aim of this study was to identify the mutational landscape, driver genes, mutation...
Harsh Goel, R. Majhi, J. Meena et al.· Medical Science· 0 citations
This review summarizes the diagnostic, prognostic, predictive, and therapeutic potential of tissue-derived, circulating, and exosomal miRNAs in NSCLC and discusses the major challenges limiting the clinical translation of miRNA-based biomarkers and therapeutics.
Imteyaz A. Khan, Surabhi Gupta, J. Meena· Journal of Human Genetics· 0 citations
This study provides a comprehensive characterization of epigenetic regulator gene alterations in JMML and highlights the importance of epigenetic dysregulation in disease pathogenesis.
Harsh Goel, R. Majhi, J. Meena et al.· Epigenomes· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.